Case-Based Learning on Shared Decision-Making for Patients With Multiple Chronic Conditions

Abstract

Shared decision-making (SDM) has emerged as a cornerstone of patient-centered care, especially in the management of individuals with multiple chronic conditions (MCCs). This article critically appraises the integration of SDM into clinical practice using a case-based learning framework, emphasizing its utility in navigating complex therapeutic choices, aligning care with patient values, and optimizing outcomes. Recent guidelines and evidence are synthesized to provide a structured approach for clinicians, highlighting epidemiological trends, underlying pathophysiology, risk stratification, and diagnostic complexities. The article further explores advances in SDM facilitation, practical challenges, and future directions for incorporating SDM into multidisciplinary care models for patients with MCCs.

Introduction

The increasing prevalence of multiple chronic conditions (MCCs) presents a profound challenge to modern healthcare systems worldwide. Traditional disease-centric models are often ill-equipped to address the intricate interplay of comorbidities, polypharmacy, and the individualized preferences of an aging population. Shared decision-making (SDM) is an evidence-based approach that fosters collaborative partnerships between clinicians and patients, incorporating patient preferences and clinical expertise into care plans. Case-based learning (CBL), rooted in adult learning theory, offers a dynamic pedagogical strategy for embedding SDM principles into daily practice. This review explores the role of CBL in equipping practitioners with the skills necessary for effective SDM in the context of MCCs, with a focus on clinical relevance, recent evidence, and best-practice recommendations.

Epidemiology / Disease Burden

MCCs affect a significant proportion of adults, particularly the elderly, with recent data indicating that over one-third of adults in developed countries live with two or more chronic illnesses. The prevalence is expected to rise due to population aging, improved survival rates, and lifestyle factors. Comorbidities such as diabetes, cardiovascular disease, chronic kidney disease, and chronic obstructive pulmonary disease commonly co-exist, contributing to a higher burden of morbidity, increased healthcare utilization, and poorer health outcomes. The complexity associated with managing MCCs underscores the need for tailored approaches that address both medical and psychosocial dimensions of care.

Pathophysiology

The pathophysiological interplay among chronic diseases is often synergistic, with shared pathways such as inflammation, metabolic dysregulation, and neurohormonal activation. For instance, diabetes and hypertension potentiate vascular damage, accelerating the progression of cardiovascular and renal diseases. Polypharmacy and drug–disease interactions further complicate management, increasing the risk of adverse effects and therapeutic conflicts. Understanding these mechanisms is crucial in framing SDM discussions enabling clinicians to articulate both the rationale and potential trade-offs inherent in complex treatment regimens.

Risk Factors

Risk factors for MCCs are multifactorial and encompass genetic predisposition, lifestyle factors (e.g., poor diet, sedentary behavior, tobacco use), socioeconomic status, and environmental exposures. Social determinants of health (SDOH) such as access to care, health literacy, and support networks significantly influence disease progression and the feasibility of management strategies. Recognizing these risk factors is essential in SDM, as they inform individualized risk–benefit assessments and the prioritization of interventions that align with patient circumstances and goals.

Clinical Features

Patients with MCCs often present with overlapping and nonspecific symptoms, functional decline, and fluctuating clinical trajectories. Symptom burden may be compounded by psychological distress, medication side effects, and limitations in activities of daily living. Careful clinical assessment, including comprehensive history-taking and functional evaluation, is pivotal in elucidating patient priorities, identifying reversible contributors, and tailoring management accordingly. SDM provides a framework to elicit patient perspectives, contextualize clinical findings, and co-create care plans that reflect both medical evidence and personal values.

Diagnosis

Diagnosing and monitoring MCCs require a holistic approach, leveraging longitudinal data, multimodal assessments, and interdisciplinary input. Diagnostic challenges stem from overlapping symptomatology, atypical presentations, and the limitations of disease-specific guidelines when applied to complex patients. Advanced diagnostic tools such as risk prediction models, frailty indices, and patient-reported outcome measures can support clinicians in stratifying risk and guiding SDM conversations regarding prognosis, diagnostic yield, and the potential impact of investigations on care planning.

Treatment & Management

Management of MCCs is inherently complex, necessitating individualized care plans that balance guideline-directed therapies with patient goals, tolerability, and life expectancy. Treatment approaches may include lifestyle modification, pharmacotherapy, disease monitoring, and palliative strategies. SDM plays a critical role in reconciling conflicting recommendations, deprescribing where appropriate, and aligning interventions with patient-defined priorities. Case-based learning exposes clinicians to real-world scenarios where management is nuanced, fostering critical thinking and adaptability in SDM application.

Recent Advances / Emerging Therapies

Recent advances in SDM include the development of digital decision aids, patient portals, and structured communication tools designed to facilitate meaningful engagement. Novel therapies such as SGLT2 inhibitors for cardiorenal protection or biologics for inflammatory conditions offer new opportunities and challenges in MCC management. Emerging models of care, including integrated care pathways and multidisciplinary teams, enhance the feasibility of SDM by streamlining communication and consolidating expertise. Ongoing research is focused on evaluating the impact of SDM on clinical outcomes, patient satisfaction, and healthcare efficiency in populations with MCCs.

Guideline Recommendations

Professional societies, including the American Geriatrics Society and the National Institute for Health and Care Excellence (NICE), increasingly advocate for SDM as a standard of care in the management of MCCs. Guidelines emphasize the need for individualized care plans, regular medication review, and the incorporation of patient preferences into decision-making. Structured frameworks such as the SHARE approach provide actionable steps for facilitating SDM, encompassing assessment of patient values, review of available options, deliberation, and shared agreement on management plans. Educational interventions, including CBL modules, are recommended to enhance clinician proficiency in SDM.

Conclusion

Case-based learning on shared decision-making equips healthcare professionals with the skills and confidence to navigate the complexities inherent in managing patients with multiple chronic conditions. By integrating clinical evidence with patient preferences, SDM fosters holistic, patient-centered care that improves satisfaction, adherence, and outcomes. Ongoing education, guideline harmonization, and system-level support are essential to embed SDM into the fabric of clinical practice, ultimately enhancing the quality and value of care for this growing patient population.